Browse Results

  • Principal Investigator: Merchan, Jaime

There are 9 clinical trial(s) matching your criteria.


A Phase 1, Dose-Finding and Signal-Seeking Study of the Safety and Efficacy of Intravenous CAVATAKTM (coxsackievirus A21, CVA21) Alone and in Combination with Pembrolizumab in Patients with Late Stage Solid Tumours (NSCLC, Castrate-Resistant Prostate Cancer, Melanoma and Bladder Cancer)

Investigator: Jaime Merchan

Institutional Protocol #: 20161016

National Clinical Trials Identifier: NCT02043665

Division: Cancer Center

Therapeutic Area: Prostate, Bladder, and Kidney Cancers

Phase: Phase I

Enrolling Since: 6/16/2017